Clinical Trial Database Needed To Confirm Prozac Adolescent Benefit – JAMA
A clinical trials database is necessary to help determine whether fluoxetine is the only SSRI that has beneficial effects in treating major depressive disorder in pediatric patients, a JAMA editorial says
You may also be interested in...
The Pharmaceutical Research & Manufacturers of America is endorsing the creation of an industry-wide database to disclose the results of clinical trials for pharmaceutical products
GlaxoSmithKline's failure to publish pediatric safety study results for its antidepressant Paxil (paroxetine) is one basis of fraud allegations lodged against the company by New York Attorney General Eliot Spitzer
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011